Recently, Xuzhou Medical Device Industry Association "Decision on awarding Xuzhou medical device Industry 2020 Integrity Enterprise", awarded Q-Array Co., Ltd. "Xuzhou medical device industry 2020 Integrity Enterprise Honorary title"; "The decision on the award of scientific and technological innovation projects" awarded Q-Array Co., Ltd. the "Second Prize of real-time fluorescence quantitative PCR instrument".
Integrity is the foundation of the enterprise and the unremitting pursuit of modern excellent enterprises. Integrity is an important intangible asset of an enterprise and the basis for its survival and sustainable development. In the future, Q-Array Co., Ltd. will continue to abide by the law on the road in the future, independent innovation, strengthen training, improve the overall quality of the enterprise, to promote the healthy development of Xuzhou medical device industry, improve the influence of the industry contribution.
The scientific and technological innovation project award is set up to stimulate the innovation consciousness of medical engineering and technical personnel, enhance the innovation ability, give play to the innovation talents of medical engineering and technical personnel, and inject vitality into the independent innovation of medical engineering practitioners. The award-winning project of Q-Array Co., Ltd. - real-time fluorescent quantitative PCR instrument, further improved product performance, strengthened the multi-link function, solved the practical problems that are not easy to get started, and won unanimous praise in the industry. In the future, Q-Array Co., Ltd. will make persistent efforts, continue to increase investment in scientific research, adhere to scientific and technological innovation and scientific popularization, promote technological innovation to multi-dimensional and multi-level expansion, and enhance the core competitiveness of enterprises.
Q-Array Co., LTD. (Q-Array) is a high-tech enterprise with molecular diagnosis and genetic testing technology as the core, integrating R&D, production and sales. The headquarters and production base are located in Xuzhou, the central city of Huaihai Economic Zone. The results transformation center is located in Suzhou Biomedical Industrial Park, a national park. In 2016, a wholly-owned R&D center was established in Toronto, Canada.
All products of Q-Array adopt original patented technology, with 12 patents and 5 software Copyrights, forming an accumulation of independent technologies in the aspects of "automatic control, image processing, optical detection, liquid path control, electronic applications, software and algorithms". It has independently developed the internationally leading "gene detection technology platform", "automatic liquid path extraction technology platform" and "automatic microbial detection technology platform".
In 2019, with the landing of Q-Array in Xuzhou Economic Development Zone, Q-Array is transforming from a single equipment manufacturer to an integrated solution provider of reagents, consumables and equipment. Based on the Anaex automatic nucleic acid rapid test line and children's respiratory tract multitest kit, which has obtained 3 European and American patents, it can detect 26 kinds of respiratory diseases, opening the era of genetic testing 3.0, and protecting the health of children's happy growth around the world.
Previous:Congratulations! Q-Array was honored with three consecutive years of prestigious awards!
Next:Come on, Wuhan! Here we come! |
Return list |
Friendly link :
All rights reserved :Jiangsu Q-Array Co., Ltd.
Technical Support: Yundingdashuju